HOSPITAL HIMA SAN PABLO FAJARDO — History
CCN 400125 | 3-year financial timeline | COVID resilience: 23/100
🛡️ Public data only — no PHI permitted on this instance.
$15M
Latest Revenue (FY2022)
-7.5%
Revenue CAGR (3yr)
-45.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $17M | $16M | $15M | -8.5% | -7.5% |
| Operating Expenses | $22M | $20M | $21M | +4.6% | -0.8% |
| Operating Margin | -26.8% | -27.8% | -45.9% | -65.5% | +0.0% |
| Net Income | $-5M | $-4M | $-7M | -51.5% | +0.0% |
| Licensed Beds | 179 | 179 | 179 | +0.0% | +0.0% |
| Total Patient Days | 13,611 | 13,308 | 12,028 | -9.6% | -6.0% |
| Medicare Day % | 7% | 9% | 5% | -47.1% | -21.4% |
| Medicaid Day % | 8% | 14% | 17% | +20.6% | +47.4% |
COVID Impact & Recovery
Resilience Score: 23/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -14.4% ($17M → $15M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-7.5%
This Hospital
+7.6%
State Avg
Latest Margin
-45.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $13M | -55.5% |
| FY2024 (proj) | $12M | -65.1% |
| FY2025 (proj) | $11M | -74.6% |